SCHEMBL9338317

SCHEMBL9338317

Cc1ncn2c1CC(C(=O)N1CCc3ccccc31)CC2

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.57
LMNA P02545 4/20 0.52
MAPT P10636 2/20 0.52
MAPK1 P28482 1/20 0.52
HSD17B10 Q99714 1/20 0.52
USP2 O75604 3/20 0.49
RAB9A P51151 2/20 0.49
KMT2A Q03164 2/20 0.49
ALDH1A1 P00352 3/20 0.47
POLB P06746 1/20 0.47
NOTUM Q6P988 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27353989 0.75 TSHR (1.00) TSHRLMNAMAPTMAPK1HSD17B10
SCHEMBL9570719 0.73 TFPI2 (0.41) TSHRMAPTRAB9ANOTUM
SCHEMBL1023583 0.72 TSHR (0.59) TSHRLMNAMAPTMAPK1HSD17B10
SCHEMBL1023584 0.72 TSHR (0.59) TSHRLMNAMAPTMAPK1HSD17B10
SCHEMBL14156261 0.71 POLB (0.86) TSHRLMNAMAPTMAPK1HSD17B10
Hydrochloric Acid SCHEMBL1023299 0.71 TSHR (0.57) TSHRLMNAMAPTMAPK1HSD17B10
Hydrochloric Acid SCHEMBL9050997 0.71 TSHR (0.57) TSHRLMNAMAPTMAPK1HSD17B10
SCHEMBL9051218 0.71 TSHR (0.51) TSHRLMNAMAPTMAPK1HSD17B10
SCHEMBL8539574 0.70 TSHR (0.59) TSHRLMNAMAPTMAPK1HSD17B10
SCHEMBL30489692 0.70 TSHR (0.76) TSHRLMNAMAPTMAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5336679-A Treatment of irritable bowel syndrome YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-08-09 US claimed
US-5336679-A Treatment of irritable bowel syndrome YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-08-09 US disclosed